Virulence
Bacteria belonging to the Enterobacter genus are gram-negative facultative anaerobes and widely distributed in nature. In the last decades, species of the genus Enterobacter have aroused greater concern, since they are increasingly associated with nosocomial infections, especially in immunocompromised patients. 1 Enterobacter species are members of ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, resistance and virulence genes, which strongly contribute to the increased pathogenicity of these bacteria. These species are extended spectrum ␤-lactamase producers and posses intrinsic resistance to ampicillin, amoxicillin, first-generation cephalosporins and cefoxitin, due to the production of constitutive AmpC ␤-lactamase. Thus Enterobacter sp. may develop antimicrobial resistance during treatment, limiting therapeutic options. 3, 4 Although studies have been pointing to the increasing prevalence of E. cloacae and. E. aerogenes as opportunistic pathogens, frequently associated with multidrug-resistance, little is known about their virulence mechanisms. 1 Therefore, the aim of this study was to characterize E. aerogenes and E. cloacae clinical isolates from Brazil regarding the genetic relationships, antimicrobial susceptibility profile, and the presence of virulence and ␤-lactamase encoding genes.
In this study a total of 14 Enterobacter isolates were included, being eight E. cloacae (EC) and six E. aerogenes (EA). Among the isolates, seven were obtained from male patients, six from female patients and one was not informed. These isolates were obtained between March 2013 to September 2016 from three Brazilian tertiary hospitals located in different regions: the southeast (Ribeirão Preto city, São Paulo state), northeast (Teresina city, Piauí state) and the north region (Manaus city, Amazonas state). These isolates were obtained from different sources such as urine, blood, anal and nasal swabs, catheter tip, oropharynx and gastrostomy tube (Table 1) .
Bacteria identification were performed by matrix-assisted laser desorption-ionization time of flight mass spectrometry (MALDI-TOF MS) using the Vitek ® MS system (bioMérieux, Marcy l'Etoile, France), according to the manufacturer's recommendations.
The antimicrobial susceptibility tests were performed by disc diffusion in Mueller-Hinton Agar (Oxoid), as recommended by the Clinical Laboratory Standards Institute (CLSI). 5 Thirty-two different antibiotic discs (Oxoid) were tested: amikacin (30 g), aztreonam (30 g), cefaclor (30 g), cefepime (30 g), cefixime (5 g), cefotaxime (30 g), ceftriaxone (30 g), ceftazidime (30 g), cefuroxime (30 g), ciprofloxacin (5 g), chloramphenicol (30 g), doripenem (10 g), doxycycline (30 g), ertapenem (10 g), gentamicin (10 g), imipenem (10 g), levofloxacin (5 g), lomefloxacin (10 g), meropenem (10 g), minocycline (30 g), nalidixic acid (30 g), nitrofurantoin (300 g), norfloxacin (10 g), ofloxacin (5 g), piperacillintazobactam (100/10 g), streptomycin (10 g), sulphonamide (300 g), tetracycline (30 g), ticarcillin-clavulanate (75/10 g), trimethoprim ( Although cefuroxime is considered as intrinsic resistance for E. cloaceae and E. aerogenes by the CLSI, 5 this antibiotic was added in the study because it is recommended by Magiorakos et al. 6 for these species. The isolates were classified as multidrug resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR), according to the criteria established by Magiorakos et al. 6 Isolates which did not fit the previous definitions were designated as not classified (NC). Genomic DNA was extracted using the phenol/chloroform method as described by Covone et al. 7 The concentration and purity were determined using a DS-11 + Spectrophotometer (DeNovix, USA).
PCR reactions were performed for the detection of the following ␤-lactamase encoding genes: bla CTX-M-Gp1 , bla CTX-M-Gp2 , GIM , and bla NDM using primers and protocols previously described. [8] [9] [10] [11] All PCR were performed using positive and negative controls. Detection of virulence genes were performed by PCR for the following genes: allS (allantoin metabolism), entB, ybtS and iutA (siderophores), kfu (iron transport and phosphotransferase function), mrkD (adhesin type 3 fimbriae), rmpA (regulator of mucoid phenotype A) according to Compain et al., 12 and ycfM (outer membrane lipoprotein) and fimH (adhesive subunit of type 1 fimbriae) according to El Fertas-Aissani et al. 13 All PCR were performed using positive and negative controls.
Confirmation of the amplified genes' identity was performed by sequencing. One of each amplicon was randomly selected and purified using the Illustra TM GFX PCR DNA and Gel Band Purification Kits (GE Healthcare, Buckinghamshire, UK). The sequencing was performed in an automated sequencer ABI 3500 × L Genetic Analyzer platform (Applied Biosystems, USA). The sequences were analyzed using ChromasPro version 1.7.6 software (Technelysium Pty. Ltd) and compared with the sequences available in the BLAST algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Enterobacterial Repetitive Intergenic Consensus PCR (ERIC-PCR) analysis was performed to evaluate the genetic similarity among the bacterial isolates of this study. ERIC-PCR was performed as previously described by Versalovic et al. 14 using primers ERIC1R (5 -ATGTAAGCTCCTGGGGATTCAC-3 ) and ERIC2 (5 -AAGTAAGTGACTGGGGTGAGCG-3 ). Band profile analysis was performed using the BioNumerics version 5.1 program (AppliedMaths, Keistraat, Belgium) for construction of the similarity dendrogram by the unweighted pair group mean method and Dice's similarity coefficient. Only bands representing amplicons between 500 and 3000 bp were considered for this analysis. The ERIC-PCR assays were performed in triplicate to be sure of the reproducibility of the amplified bands.
Among the 14 isolates, eight (57.1%) were classified as MDR according to the criteria established by Magiorakos et al., 6 being five isolates of E. cloacae (EC02, EC03, EC04, EC05 and EC06) and three E. aerogenes (EA01, EA05 and EA06) (Fig. 1) . All isolates showed non-susceptibility (i.e. either intermediate or resistance) to sulphonamide; 12 (85.7%) isolates were non-susceptible to cefaclor and nitrofurantoin; 11 (78.6%) to doxycycline; 11 (78.6%) to cefixime, trimethoprim-sulfamethoxazole, trimethoprim and nalidixic acid; nine (64.3%) to streptomycin; eight (57.1%) to cefuroxime; six (42.9%) to lomefloxacin, ertapenem and minocycline; five (35.7%) to ceftazidime, cefepime, ceftriaxone and piperacillin-tazobactam; four (28.6%) to amikacin, gentamicin, tobramycin, ofloxacin, cefotaxime, aztreonam and ticarcillin-clavulanate; three (21.43%) to ciprofloxacin, levofloxacin, norfloxacin, doripenem and tetracycline; two (14.3%) to meropenem and just one isolate (7.14%) to chloramphenicol ( Table 1) .
The resistance profile found in the studied isolates corroborate with a study conducted by Cabral et al., 4 which analyzed a Brazilian collection of E. aerogenes and E. cloacae complex isolates, and found the lowest resistance rates in amikacin, gentamicin and tobramycin. However, they found low levels of resistance to trimethoprim-sulfamethoxazole while we found 71.4% resistance for this antibiotic. Fortunately, with the exception of isolate EA06, all isolates were sensitive to imipenem, since papers have described that this antibiotic remains one of the most effective in combating E. cloacae infections. However, there are several works reporting the adaptive response of clinical isolates of Enterobacter sp. to imipenem by regulation of porins. 4, 15 In this study 16 different ␤-lactamase encoding genes belonging to group 2 and 3, according to Bush and Jacoby 16 were investigated, and a total of 18 amplicons from six different genes (bla CTX-M-Gp1 , bla CTX-M-Gp2 , bla SHV , bla VEB , bla GES , and bla KPC ) were detected (Fig. 1) . The most prevalent gene was 
